These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1805610)

  • 21. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lead nephropathy in Queensland: alternative methods of diagnosis.
    Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM
    Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulated lead exposure and risk of age-related cataract in men.
    Schaumberg DA; Mendes F; Balaram M; Dana MR; Sparrow D; Hu H
    JAMA; 2004 Dec; 292(22):2750-4. PubMed ID: 15585735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study.
    Hu H; Payton M; Korrick S; Aro A; Sparrow D; Weiss ST; Rotnitzky A
    Am J Epidemiol; 1996 Oct; 144(8):749-59. PubMed ID: 8857824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
    Seaton CL; Lasman J; Smith DR
    Toxicol Appl Pharmacol; 1999 Sep; 159(3):153-60. PubMed ID: 10486301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lead poisoning from mobilization of bone stores during thyrotoxicosis.
    Goldman RH; White R; Kales SN; Hu H
    Am J Ind Med; 1994 Mar; 25(3):417-24. PubMed ID: 8160659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of chelation therapy in lead nephropathy.
    Germain MJ; Braden GL; Fitzgibbons JP
    Arch Intern Med; 1984 Dec; 144(12):2419-20. PubMed ID: 6439141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic chelation therapy in occupational lead poisoning: a review.
    Bridbord K; Blejer HP
    Am Ind Hyg Assoc J; 1977 Oct; 38(10):536-42. PubMed ID: 411363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of bone and blood lead on plasma lead levels in environmentally exposed adults.
    Hernández-Avila M; Smith D; Meneses F; Sanin LH; Hu H
    Environ Health Perspect; 1998 Aug; 106(8):473-7. PubMed ID: 9681974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance and validity of a shortened lead chelation test.
    Apostoli P; Porru S; Duca P; Ferioli A; Alessio L
    J Occup Med; 1990 Nov; 32(11):1124-9. PubMed ID: 2124260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lead intoxication in Sydney Harbour Bridge workers.
    Pollock CA; Ibels LS
    Aust N Z J Med; 1988 Feb; 18(1):46-52. PubMed ID: 3134881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.
    Lee BK; Schwartz BS; Stewart W; Ahn KD
    Occup Environ Med; 1995 Jan; 52(1):13-9. PubMed ID: 7697134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report from the CDC. Is lead exposure a risk factor for bone loss?
    Potula V; Kaye W
    J Womens Health (Larchmt); 2005; 14(6):461-4. PubMed ID: 16114996
    [No Abstract]   [Full Text] [Related]  

  • 34. Cumulative lead exposure is associated with reduced olfactory recognition performance in elderly men: The Normative Aging Study.
    Grashow R; Sparrow D; Hu H; Weisskopf MG
    Neurotoxicology; 2015 Jul; 49():158-64. PubMed ID: 26121922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moderate lead poisoning: trends in blood lead levels in unchelated children.
    Markowitz ME; Bijur PE; Ruff HA; Balbi K; Rosen JF
    Environ Health Perspect; 1996 Sep; 104(9):968-72. PubMed ID: 8899376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of lead exposure and motor performance mediated by cerebral white matter change.
    Bleecker ML; Ford DP; Vaughan CG; Walsh KS; Lindgren KN
    Neurotoxicology; 2007 Mar; 28(2):318-23. PubMed ID: 16781776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid and EDTA treatment of lead toxicity in rats.
    Goyer RA; Cherian MG
    Life Sci; 1979 Jan; 24(5):433-8. PubMed ID: 107387
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning.
    Weisskopf MG; Hu H; Mulkern RV; White R; Aro A; Oliveira S; Wright RO
    Environ Health Perspect; 2004 Apr; 112(5):620-5. PubMed ID: 15064171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
    Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
    Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychologic and postural sway improvement after Ca(++)-EDTA chelation for mild lead intoxication.
    Linz DH; Barrett ET; Pflaumer JE; Keith RE
    J Occup Med; 1992 Jun; 34(6):638-41. PubMed ID: 1619495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.